I3C 200mg.
I3C 200mg supplementation for targeted health support. I3C is converted to DIM and other metabolites that affect estrogen breakdown pathways. It promotes conversion of estrogen to less potent forms (2-hydroxyestrone vs 16-hydroxyestrone).
Reviewed March 2026
- Category
- Hormone
What I3C 200mg is, and what it does.
- Does it work
- Good evidence for estrogen metabolism modification. 200mg is a solid clinical dose. DIM is often preferred now because it's the active metabolite, but I3C still works.
- How much to take
- 200-400mg daily is the studied range. 200mg is a good starting point. Split dosing may improve tolerability.
- Time to feel it
- Shifts in urinary estrogen metabolite ratios show up over about four to eight weeks of daily use. That change reads on a lab test rather than as a sensation.
- The first dose
- Day one is quiet. The dose condenses in stomach acid into DIM and related indoles, and what that starts shows up as a urinary metabolite ratio over the weeks after.
- With regular use
- Improved estrogen metabolite ratios measurable on testing. Some people notice reduced estrogen dominance symptoms over 4-8 weeks.
- How well tolerated
- Generally well tolerated. Affects hormone metabolism, so not for everyone. GI effects possible. Avoid in pregnancy.
- How it feels
- You don't feel it directly. Benefits are through improved hormone metabolism.
- The overlooked benefit
- It induces CYP1A2, the enzyme that clears caffeine, so your usual coffee can land differently. Worth mentioning to a prescriber alongside anything else you take.
100 to 200mg a day is where I3C 200mg works.
Source: Bradlow et al. J Cell Biochem Suppl 1999; Reed et al. Nutr Cancer 2005
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Shifts estrogen metabolismMultiple studies show 2/16-OHE1 ratio improvement
- Supports hormone balanceMechanism validated, clinical outcomes variable
- May reduce cancer riskEpidemiological and mechanistic support, not proven clinically
- Helps PMS symptomsSmall studies and clinical experience support
Questions people ask about I3C 200mg.
- What's the difference between I3C and DIM?
- I3C converts to DIM in your stomach. DIM is more stable and the direct active compound. I3C gives you DIM plus other metabolites.
- How much broccoli equals 200mg I3C?
- You'd need about 2-3 pounds of raw broccoli daily. Supplementation is the only practical way to get therapeutic doses.
- Can men take I3C?
- Yes. Men use it for estrogen management, especially those with higher body fat or on testosterone therapy. Same dosing.
- How long until I see results?
- Hormone metabolism changes take 4-8 weeks to manifest. Urinary estrogen metabolite tests can show changes earlier.
- Will it lower my estrogen too much?
- It shifts metabolism, not total levels dramatically. But sensitive individuals should start low. Monitor how you feel.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Indole-3-carbinol condenses in stomach acid to DIM, which is the species that reaches the circulation. Carrying both means the delivered dose does not depend entirely on stomach acidity.
Indole-3-carbinol shifts estrogen hydroxylation toward the 2-hydroxy route, and glucarate supports glucuronide conjugates staying intact for excretion by limiting beta-glucuronidase activity in the gut. The two act on consecutive steps of the same clearance sequence.
The 2-hydroxy metabolites that indole-3-carbinol favours are methylated by COMT using S-adenosylmethionine. Betaine regenerates methionine and keeps that methyl pool supplied.
Methylfolate donates a carbon into methionine synthase, feeding the S-adenosylmethionine pool that the COMT methylation step draws on. That step follows the hydroxylation shift indole-3-carbinol produces.
Catechol-O-methyltransferase requires magnesium at its active site to transfer the methyl group. Without it the downstream methylation of catechol metabolites runs slowly.
Both come from cruciferous glucosinolates but act differently, indole-3-carbinol mainly on hydroxylation routing and sulforaphane on Nrf2 driven phase II enzyme expression. They cover induction and routing rather than duplicating each other.
Indoles from cruciferous sources induce CYP1A2, the enzyme that clears most caffeine. A regular indole dose can shorten how long a given caffeine dose lasts.
Melatonin is metabolised largely by CYP1A2, which indole-3-carbinol induces. The same induction that shifts estrogen routing can shorten melatonin exposure.
Indole-3-carbinol comes from glucobrassicin, while broccoli sprout extract is standardised to glucoraphanin, the precursor of sulforaphane. Both are myrosinase-released breakdown products of the same class of plant compound but they act on different downstream targets, indoles on cytochrome P450 1 family enzymes and isothiocyanates on Nrf2-linked phase II enzymes. Taken together they cover both arms of that chemistry rather than duplicating one. This is pathway biochemistry, not a combination trial.
Indole-3-carbinol is chemically unstable in acid and condenses in the stomach into diindolylmethane and larger indole oligomers, which are the species recovered in plasma. Adequate gastric acidity is therefore part of the conversion step rather than an incidental detail. Betaine hydrochloride is used in formulations to support normal gastric acidity, which is the condition that conversion depends on. No trial has tested the pair; the dependence itself is established chemistry.
Indoles induce cytochrome P450 1A activity, which raises the flux of oxidised intermediates that then need conjugation to be cleared. Glutathione S-transferase handles much of that conjugation and depends on glutathione, whose rate-limiting building block is cysteine. N-acetylcysteine supplies cysteine for normal glutathione synthesis. The rationale is mechanistic sequencing of phase I and phase II activity, not a measured outcome.
Glutathione is the conjugating substrate that phase II enzymes use to make oxidised metabolites water soluble for excretion. Because indoles push phase I activity upward, phase II capacity is what determines whether the added intermediates are cleared smoothly. Oral glutathione absorption is modest and debated, which is why cysteine donors are often used instead. Presented as mechanism, with the absorption caveat intact.
Glutathione peroxidases and thioredoxin reductases are selenoproteins, so selenium status sets the ceiling on how fast reduced glutathione and thioredoxin can be recycled. Higher phase I turnover raises the demand on exactly those enzymes. The cofactor relationship is textbook and needs no trial. Selenium also has a narrow intake range, so total intake from all sources matters.
Methylation is one of the routes by which oxidised catechol metabolites are further processed, and it draws on S-adenosylmethionine regenerated through the folate and B12 dependent methionine cycle. Vitamin B12 is the cofactor for methionine synthase in that cycle. Supporting normal one-carbon flux keeps methylation capacity available while indole intake is raised. Cofactor biochemistry, not an outcome claim.
Silymarin constituents have been reported in pharmacology literature to modulate several cytochrome P450 and UGT activities, while indoles push cytochrome P450 1A activity in the other direction. Combining two enzyme modulators makes the net effect on any co-administered compound harder to predict rather than simply additive. The direction of the interaction is not established in humans at supplement doses. Anyone taking prescription medication should raise the combination with their prescriber.
Inositol acts as a second messenger precursor in insulin and gonadotropin signalling, a different level of biology from indole effects on hepatic estrogen metabolism. The two are combined in formulation practice because their supposed roles do not overlap. No combination trial supports the pairing. It is recorded here as formulation practice at low confidence.
Flaxseed carries lignans that gut bacteria convert to enterolignans, which bind weakly at estrogen receptors, while indoles act earlier on hepatic hydroxylation of estrogens. The two act at different points on the same broad pathway, so effects are not simply interchangeable. Flaxseed oil pressed from seed carries far less lignan than whole or milled seed, which limits how much of this applies to the oil. Low confidence and mechanistic only.
Nothing specific on file for I3C 200mg. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What I3C 200mg actually does.
Indole-3-carbinol is the myrosinase-released breakdown product of glucobrassicin, a glucosinolate concentrated in cabbage, broccoli, kale and other brassicas.
In the acidic stomach indole-3-carbinol condenses into diindolylmethane and higher indole oligomers, and these condensation products, not the parent molecule, are what circulate after an oral dose.
Indoles of this class are aryl hydrocarbon receptor ligands, and receptor activation raises transcription of cytochrome P450 1A1, 1A2 and 1B1.
Cytochrome P450 1A2 catalyses 2-hydroxylation of estradiol while 1B1 favours 4-hydroxylation, so shifting the relative activity of those enzymes changes the mix of hydroxylated estrogen metabolites produced.
Where I3C 200mg comes from.
It can come from cruciferous vegetables such as broccoli and cabbage, or it can be made in a lab. Either way it is the same molecule, and the useful question is what else is in the powder rather than where it started.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
Cruciferous material supplies glucobrassicin; synthetic routes start from indole and a one-carbon donor.
In the plant route, tissue disruption releases myrosinase which hydrolyses glucobrassicin toward indole-3-carbinol; the synthetic route installs the hydroxymethyl group directly on indole.
The indole fraction is taken into solvent and separated from the bulk plant or reaction matrix.
Material is recrystallised and dried to a defined assay, since residual moisture accelerates degradation.
Powder is blended and encapsulated, commonly with a desiccant in the pack.
Getting I3C 200mg from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.